Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Preparation methods for preparing tylosin-containing encapsulated core material with tylosin stripping solution and micro-capsule of tylosin-containing encapsulated core material

A technology of back-extraction and tylosin, which is applied in the field of preparation of veterinary preparations, can solve the problems of drug loss, dust pollution, increase the risk of fire and explosion, etc. Risk of flammability and explosion, effect of improving palatability and stability

Inactive Publication Date: 2017-10-24
中农华威生物制药(湖北)有限公司
View PDF4 Cites 4 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0004] 1. High energy consumption: producing 1 ton of tylosin tartrate or tylosin phosphate requires about 3000 kWh of electricity and about 3 tons of steam, equivalent to RMB 3000-4500 in total
[0005] 2. Large product loss: 4.5-9.6% of tylosin is lost during the spray drying process. Therefore, the production yield of tylosin is greatly reduced. A factory with an annual output of 1,000 tons of tylosin, In this production process alone, 45-96 tons of tylosin are lost every year, worth about 12-27 million yuan
[0006] 3. There is dust pollution in spray drying
The use of these organic solvents in production, in addition to cost factors, also has potential safety hazards (such as solvent poisoning of production personnel and increased risk of fire and explosion), and there are still shortcomings such as about 4% drug loss.

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Examples

Experimental program
Comparison scheme
Effect test

example 1

[0028] Example 1. Preparation of drug microcapsules containing tylosin tartrate

[0029] (1) preparation of the capsule core: 3 liters of purified back extract containing 662 grams of tylosin tartrate, mixed with 4 kilograms of corncob powder with a particle size between 40-100 mesh sieve holes, fully stirred, Then dry at room temperature (or dry at 40-60° C.) to obtain about 4800 grams of capsule core.

[0030] (2) Coating: Melt 0.42 kg of glyceryl monostearate at 70-80°C and keep it at this temperature, mix it with the capsule core obtained in step (1), stir well, mix well, and cool to room temperature to obtain drug microcapsules containing tylosin tartrate.

example 2

[0031] Example 2. Preparation of capsule core containing tylosin tartrate

[0032] 3 liters of purified back extracts containing 662 grams of tylosin tartrate are mixed with 3 kilograms of corncob powder between 40-100 mesh sieves, fully stirred, and then dried at room temperature (or at 40-100 meshes). Drying at 60° C.) to obtain about 3800 grams of capsule core containing tylosin tartrate.

example 3

[0033] Example 3. Preparation of capsules containing tylosin phosphate

[0034] Mix 1 liter of the purified back extract containing 280 grams of tylosin phosphate with 1.5 kilograms of corncob flour with a particle size between 40-100 mesh, stir well, and reduce the concentration at 40-60°C Press and dry to obtain about 1875 grams of capsule core containing tylosin phosphate.

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention discloses preparation methods for preparing corncob powder and tylosin (tylosin tartrate or tylosin phosphate)-containing encapsulated core material by directly combining a purified tylosin stripping solution (an aqueous solution containing the tylosin tartrate or the tylosin phosphate) with corncob powder and a micro-capsule of the encapsulated core material. By using the preparation methods provided by the invention to prepare the tylosin / corncob powder-containing encapsulated core material and the micro-capsule of the encapsulated core material, the yield is higher, and the energy consumption is lower; without using an organic solvent, the flammable and combustible risks and the dust pollution are lowered, the intermediate manufacturing cost and the unnecessary pollution are reduced, and a product can be directly used for clinical veterinary medicine.

Description

technical field [0001] The present invention relates to preparation technology for veterinary preparations, in particular to the preparation of corn cob powder containing corn cob powder and Cystic cores of tylosin (tylosin tartrate or tylosin phosphate) and microcapsules thereof. Background technique [0002] Tylosin is a special antibacterial drug for livestock and poultry. Among the tylosin preparations that have been marketed, the most widely used is the premix containing tylosin, which is composed of tylosin tartrate with a purity greater than 80%. Or tylosin phosphate and pharmaceutical excipients are prepared. Tylosin is a liquid fermentation product of Streptomyces freundii. The post-treatment of its fermentation liquid is: adding a flocculant (such as aluminum sulfate or aluminum chloride) to the fermentation liquid, fully mixing, and separating the solid and liquid to obtain the fermentation filtrate; After adjusting the pH of the filtrate, carry out liquid-liqui...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Applications(China)
IPC IPC(8): A61K9/50A61K31/7048A61K47/46A61P31/04
Inventor 王玉万韩可可翁志飞任雅楠沈力
Owner 中农华威生物制药(湖北)有限公司
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products